104 related articles for article (PubMed ID: 32771892)
1. Targeted MRI and chemotherapy of ovarian cancer with clinic available nano-drug based nanoprobe.
Dong L; Zhang X; Cai L; Zuo F; Zhao M; Wang Q; Zhang S; Xu K; Li J
Biomed Pharmacother; 2020 Oct; 130():110585. PubMed ID: 32771892
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers.
Gawde KA; Sau S; Tatiparti K; Kashaw SK; Mehrmohammadi M; Azmi AS; Iyer AK
Colloids Surf B Biointerfaces; 2018 Jul; 167():8-19. PubMed ID: 29625422
[TBL] [Abstract][Full Text] [Related]
3. An experimental study of ovarian cancer imaging and therapy by paclitaxel-loaded phase-transformation lipid nanoparticles combined with low-intensity focused ultrasound.
Gao Y; Chen S; Li W; Wang H; Xiao K; Wu L; Li Y; Li H; Li H; Zhu Y
Biochem Biophys Res Commun; 2018 Sep; 504(1):203-210. PubMed ID: 30180951
[TBL] [Abstract][Full Text] [Related]
4. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia.
Chen L; Wu Y; Wu H; Li J; Xie J; Zang F; Ma M; Gu N; Zhang Y
Acta Biomater; 2019 Sep; 96():491-504. PubMed ID: 31302299
[TBL] [Abstract][Full Text] [Related]
5. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
6. Size-based anti-tumoral effect of paclitaxel loaded albumin microparticle dry powders for inhalation to treat metastatic lung cancer in a mouse model.
Chaurasiya B; Huang L; Du Y; Tang B; Qiu Z; Zhou L; Tu J; Sun C
Int J Pharm; 2018 May; 542(1-2):90-99. PubMed ID: 29496457
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy.
Moon H; Kang J; Sim C; Kim J; Lee H; Chang JH; Kim H
J Control Release; 2015 Nov; 218():63-71. PubMed ID: 26432554
[TBL] [Abstract][Full Text] [Related]
8. Anti-EGFR antibody conjugated thiol chitosan-layered gold nanoshells for dual-modal imaging-guided cancer combination therapy.
Manivasagan P; Nguyen VT; Jun SW; Hoang G; Mondal S; Kim H; Doan VHM; Kim J; Kim CS; Oh J
J Control Release; 2019 Oct; 311-312():26-42. PubMed ID: 31401198
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
Lv W; Cheng L; Li B
Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
[TBL] [Abstract][Full Text] [Related]
10. Targeted paclitaxel nanoparticles modified with follicle-stimulating hormone β 81-95 peptide show effective antitumor activity against ovarian carcinoma.
Zhang X; Chen J; Kang Y; Hong S; Zheng Y; Sun H; Xu C
Int J Pharm; 2013 Sep; 453(2):498-505. PubMed ID: 23811008
[TBL] [Abstract][Full Text] [Related]
11. A targeting drug delivery system for ovarian carcinoma: transferrin modified lipid coated paclitaxel-loaded nanoparticles.
Li R; Zhang Q; Wang XY; Chen XG; He YX; Yang WY; Yang X
Drug Res (Stuttg); 2014 Oct; 64(10):541-7. PubMed ID: 24443309
[TBL] [Abstract][Full Text] [Related]
12. Melanin-loaded biocompatible photosensitive nanoparticles for controlled drug release in combined photothermal-chemotherapy guided by photoacoustic/ultrasound dual-modality imaging.
Wang W; Jing T; Xia X; Tang L; Huang Z; Liu F; Wang Z; Ran H; Li M; Xia J
Biomater Sci; 2019 Oct; 7(10):4060-4074. PubMed ID: 31475710
[TBL] [Abstract][Full Text] [Related]
13. Microemulsion and bovine serum albumin nanoparticles as a novel hybrid nanocarrier system for efficient multifunctional drug delivery.
Gharbavi M; Danafar H; Sharafi A
J Biomed Mater Res A; 2020 Aug; 108(8):1688-1702. PubMed ID: 32196926
[TBL] [Abstract][Full Text] [Related]
14. Development of fluorescence/MR dual-modal manganese-nitrogen-doped carbon nanosheets as an efficient contrast agent for targeted ovarian carcinoma imaging.
Han C; Xie T; Wang K; Jin S; Li K; Dou P; Yu N; Xu K
J Nanobiotechnology; 2020 Nov; 18(1):175. PubMed ID: 33256741
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals.
Sun B; Taha MS; Ramsey B; Torregrosa-Allen S; Elzey BD; Yeo Y
J Control Release; 2016 Aug; 235():91-98. PubMed ID: 27238443
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel loaded magnetic nanocomposites with folate modified chitosan/carboxymethyl surface; a vehicle for imaging and targeted drug delivery.
Bano S; Afzal M; Waraich MM; Alamgir K; Nazir S
Int J Pharm; 2016 Nov; 513(1-2):554-563. PubMed ID: 27651326
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled PEGylated albumin nanoparticles (SPAN) as a platform for cancer chemotherapy and imaging.
Lee JE; Kim MG; Jang YL; Lee MS; Kim NW; Yin Y; Lee JH; Lim SY; Park JW; Kim J; Lee DS; Kim SH; Jeong JH
Drug Deliv; 2018 Nov; 25(1):1570-1578. PubMed ID: 30044159
[TBL] [Abstract][Full Text] [Related]
18. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
[TBL] [Abstract][Full Text] [Related]
19. An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery.
Li S; Su Z; Sun M; Xiao Y; Cao F; Huang A; Li H; Ping Q; Zhang C
Int J Pharm; 2012 Oct; 436(1-2):248-57. PubMed ID: 22732672
[TBL] [Abstract][Full Text] [Related]
20. Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomography imaging and chemotherapy of breast tumors.
Zhu Y; Wang X; Chen J; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
J Control Release; 2016 Dec; 244(Pt B):229-239. PubMed ID: 27568289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
